State of Tennessee, Department of Treasury’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,538
Closed -$68.8K 1749
2023
Q2
$68.8K Sell
3,538
-2,618
-43% -$50.9K ﹤0.01% 1687
2023
Q1
$175K Sell
6,156
-2,189
-26% -$62.1K ﹤0.01% 1560
2022
Q4
$244K Buy
8,345
+328
+4% +$9.59K ﹤0.01% 1494
2022
Q3
$212K Buy
8,017
+390
+5% +$10.3K ﹤0.01% 1522
2022
Q2
$339K Sell
7,627
-64
-0.8% -$2.85K ﹤0.01% 1428
2022
Q1
$381K Buy
7,691
+645
+9% +$32K ﹤0.01% 1474
2021
Q4
$359K Buy
7,046
+407
+6% +$20.7K ﹤0.01% 1461
2021
Q3
$371K Sell
6,639
-398
-6% -$22.2K ﹤0.01% 1442
2021
Q2
$301K Sell
7,037
-27
-0.4% -$1.16K ﹤0.01% 1504
2021
Q1
$295K Buy
7,064
+404
+6% +$16.9K ﹤0.01% 1458
2020
Q4
$310K Buy
6,660
+569
+9% +$26.5K ﹤0.01% 1391
2020
Q3
$258K Hold
6,091
﹤0.01% 1341
2020
Q2
$292K Sell
6,091
-524
-8% -$25.1K ﹤0.01% 1312
2020
Q1
$304K Sell
6,615
-355
-5% -$16.3K ﹤0.01% 1257
2019
Q4
$419K Sell
6,970
-1,128
-14% -$67.8K ﹤0.01% 1313
2019
Q3
$458K Buy
8,098
+552
+7% +$31.2K ﹤0.01% 1303
2019
Q2
$420K Sell
7,546
-155
-2% -$8.63K ﹤0.01% 1259
2019
Q1
$389K Sell
7,701
-209
-3% -$10.6K ﹤0.01% 1313
2018
Q4
$319K Buy
7,910
+1,879
+31% +$75.8K ﹤0.01% 1322
2018
Q3
$418K Buy
6,031
+253
+4% +$17.5K ﹤0.01% 1341
2018
Q2
$437K Sell
5,778
-202
-3% -$15.3K ﹤0.01% 1351
2018
Q1
$315K Sell
5,980
-369
-6% -$19.4K ﹤0.01% 1398
2017
Q4
$339K Sell
6,349
-691
-10% -$36.9K ﹤0.01% 1425
2017
Q3
$420K Sell
7,040
-445
-6% -$26.5K ﹤0.01% 1362
2017
Q2
$590K Hold
7,485
﹤0.01% 1314
2017
Q1
$621K Buy
7,485
+1,130
+18% +$93.8K ﹤0.01% 1304
2016
Q4
$504K Hold
6,355
﹤0.01% 1345
2016
Q3
$445K Buy
+6,355
New +$445K ﹤0.01% 1283